ERBB2 and breast carcinoma: Irudayaraj et al. synthesized fluorescent BSA-protected AuNCs (~ 2 nm) conjugated with Herceptin (AuNCs-Her) [194], which were used for specific targeting in ErbB2 overexpressed breast cancer towards both imaging and cancer therapy.